# Innovative Biosensors

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/innovative-biosensors

- Industry: Medical Devices & Equipment
- Headquarters: Rockville, US
- Website: www.innovativebiosensors.com
- Total disclosed funding: $17M
- Latest round: Series A (Mar 14, 2012)
- Investors on record: 7

## About

Innovative Biosensors, Inc. develops advanced biosensing technologies aimed at improving health monitoring and diagnostics through real-time biomolecule detection, catering primarily to healthcare providers and research institutions.Founded in 2003 and headquartered in Rockville, US, Innovative Biosensors, Inc. specializes in biosensing technology. The company raised USD 1.52 mn in Series A funding in March 2012 from investors including CNF Investments and Chart Venture Partners. The total amount raised by the company stands at USD 1.52 mn with a current valuation of USD 16.998 mn.Innovative Biosensors specializes in developing advanced biosensing technologies that address health monitoring and diagnostics challenges. Their core offerings include biosensor devices designed for healthcare providers, research institutions, and laboratories, focusing on real-time biomolecule detection to enhance patient outcomes. The company targets markets in North America and Europe, ensuring compliance with regulatory standards and addressing healthcare professionals' needs.Innovative Biosensors generates revenue through direct sales of its biosensor devices to healthcare organizations and partnerships with research institutions. The company provides these devices as standalone products or within subscription services for continuous monitoring. This model allows for ongoing support and software updates, thereby maintaining optimal performance in their diagnostic technologies.Looking ahead, Innovative Biosensors plans to expand its product line with new biosensor technologies set for release later this year. The company is also targeting expansion into additional markets in Asia by 2024. The recent funding of USD 1.52 mn from the Series A round will support these initiatives, particularly in product development and market entry strategies.

## Funding rounds

- Series A, Mar 14, 2012, $1.5M — EQT Life Sciences, Harbert Management, Chart Venture Partners, CNF Investments
- Series B, May 1, 2008, $9.5M — EQT Life Sciences, Harbert Management, New Markets Venture Partners, Chart Venture Partners, CNF Investments
- Series A, Sep 15, 2006, $2.8M — Harbert Management, Maryland Department of Business and Economic Development, Chart Venture Partners, CNF Investments
- Series A, May 26, 2005, $3.5M — Harbert Management, New Markets Venture Partners, Maryland Venture Fund

## Investors

- Harbert Management (https://capitalatlas.ai/funds/harbert-management) — Series A, Series B
- New Markets Venture Partners (https://capitalatlas.ai/funds/new-markets-venture-partners) — Series A, Series B
- Maryland Venture Fund (https://capitalatlas.ai/funds/maryland-venture-fund) — Series A
- Maryland Department of Business and Economic Development — Series A
- Chart Venture Partners (https://capitalatlas.ai/funds/chart-venture-partners) — Series A, Series B
- CNF Investments (https://capitalatlas.ai/funds/cnf-investments) — Series A, Series B
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series B, Series A